Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Is The Personalized Cell Therapy Market Expected To Grow In Terms Of Size?

The market for personalized cell therapy has experienced significant expansion in the previous years. Its growth is forecasted to rise from $17.11 billion in 2024 to $20.83 billion in 2025, representing a compound annual growth rate (CAGR) of 21.8%. This growth trajectory during the historic period is influenced by several factors that include a heightened awareness of personalized medicine, surge in healthcare expenditure, increased governmental initiatives, augmented funding for clinical research, and a prevalence in neurological disorders.

Anticipated to experience a rapid expansion in the upcoming years, the market size of personalized cell therapy is projected to reach $46.24 billion by 2029, boasting a compound annual growth rate (CAGR) of 22.1%. The prospective increase during the forecasted period is due to factors such as increasing number of clinical trials, a surge in chronic disease cases, a growing aging population, an upswing in cancer prevalence, and an upward trend in the usage of regenerative medicine. The upcoming trends to note in this forecasted timeframe include advancements in technology, the incorporation of Artificial Intelligence (AI), personalized vaccines, bioinformatics, and microfluidic technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19137&type=smp

Which Key Factors Are Fueling Growth In The Personalized Cell Therapy Market?

The escalating prevalence of neurological disorders is anticipated to fuel the expansion of the personalized cell therapy market. Characterized by symptoms such as sensory disturbances, motor function impairments, and cognitive deficits, neurological disorders comprise various conditions impacting the brain, spinal cord, and nerves. They have their roots in factors such as aging populations, lifestyle modifications, and environmental stress, which all contribute to increased rates of neurodegenerative diseases. Personalized cell therapy, providing customized treatments addressing specific patient requirements, is crucial for these disorders. It holds the potential to regenerate impaired neural tissue, thereby enhancing results in intricate, unique conditions. To illustrate, statistics from the Parkinson Foundation, a US governmental body, revealed in December 2022 that the annual incidence of Parkinson’s disease (PD) among the elderly is 50% above the current prediction of 60,000 cases. Furthermore, by 2030, an additional 1.2 million Americans are expected to be diagnosed with Parkinson’s disease. Thus, the growing occurrence of neurological disorders is propelling the growth of the personalized cell therapy market.

How Is The Personalized Cell Therapy Market Categorized Across Applications And Types?

The personalized cell therapymarket covered in this report is segmented –

1) By Cell Type: Lymphocytes; Mesenchymal Stem Cell; Hematopoietic Stem Cell; Other Cell Type

2) By Technique: Platelet Transfusions; Bone Marrow Transplantation; Packed Red Cell Transfusions; Organ Transplantation

3) By Application: Cardiovascular Diseases; Neurological Disorders; Inflammatory Diseases; Diabetes; Cancer; Other Applications

4) By End-User: Hospital; Homecare; Specialty Clinics; Other End-User

Subsegments:

1) By Lymphocytes: T Cells; Natural Killer (NK) Cells; Regulatory T Cells

2) By Mesenchymal Stem Cells (MSCs): Bone Marrow-Derived MSCs; Adipose Tissue-Derived MSCs; Umbilical Cord-Derived MSCs

3) By Hematopoietic Stem Cells: Autologous Hematopoietic Stem Cells; Allogeneic Hematopoietic Stem Cells

4) By Other Cell Types: Dendritic Cells; Fibroblasts; Endothelial Cells

How Are Industry Trends Steering The Expansion Of The Personalized Cell Therapy Market?

Prominent businesses in the personalized cell therapy market are establishing strategic alliances to expedite the development and commercialization of novel therapies. These partnerships allow companies to consolidate resources, knowledge, and technology to improve their research and development capabilities, simplify clinical trials, and navigate regulatory procedures more efficiently. For example, Century Therapeutics Inc., a US-based biotech firm, forged a partnership with Bristol Myers Squibb (BMS), a US-based biopharmaceutical enterprise, in October 2022 to create and market allogeneic cell therapies. This partnership relies on Century’s breakthrough induced pluripotent stem cell (iPSC) technology to generate engineered natural killer (NK) and T cell therapies for hematologic malignancies and solid tumors. The deal includes the creation of up to four individual cell therapy projects, primarily focusing on acute myeloid leukemia (AML) and multiple myeloma. These projects will use engineered NK cells or gamma delta T cells produced from iPSCs.

Which Firms Are Making The Biggest Impact In The Personalized Cell Therapy Market?

Major companies operating in the personalized cell therapy marker are AbbVie Inc., Bristol-Myers Squibb Company, GlaxoSmithKline plc, Gilead Sciences Inc., Cipla Limited, Poseida Therapeutics Inc., Sangamo Therapeutics Inc., Nkarta Therapeutics Inc., Intellia Therapeutics Inc., Tessa Therapeutics Pte Ltd., Atara Biotherapeutics Inc., Adaptimmune Therapeutics plc, Precision BioSciences Inc., Editas Medicine Inc., Cellectis S.A., Gracell Biotechnologies Inc., Mesoblast Limited, Fate Therapeutics Inc., Athersys Inc., Bellicum Pharmaceuticals Inc., Celyad Oncology SA, Century Therapeutics Inc., Gamida Cell Ltd., CRISPR Therapeutics AG, Allogene Therapeutics Inc.

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/personalized-cell-therapy-global-market-report

Which Region Holds The Greatest Opportunity For Personalized Cell Therapy Market Expansion?

North America was the largest region in the personalized cell therapy market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the personalized cell therapy marker report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=19137&type=smp

Browse Through More Reports Similar to the Global Personalized Cell Therapy Market 2025, By The Business Research Company

Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cells-therapy-global-market-report

Stem Cells Therapy Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/stem-cells-therapy-global-market-report

Cell Therapy Technologies Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/cell-therapy-technologies-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model